398 related articles for article (PubMed ID: 32135232)
1. Profile of Pathogenic Proteins and MicroRNAs in Plasma-derived Extracellular Vesicles in Alzheimer's Disease: A Pilot Study.
Li F; Xie XY; Sui XF; Wang P; Chen Z; Zhang JB
Neuroscience; 2020 Apr; 432():240-246. PubMed ID: 32135232
[TBL] [Abstract][Full Text] [Related]
2. Prediction of P-tau/Aβ42 in the cerebrospinal fluid with blood microRNAs in Alzheimer's disease.
Jia L; Zhu M; Yang J; Pang Y; Wang Q; Li Y; Li T; Li F; Wang Q; Li Y; Wei Y
BMC Med; 2021 Nov; 19(1):264. PubMed ID: 34775974
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of endogenous control miRNAs in plasma samples for normalization of qPCR data for Alzheimer's disease.
Dakterzada F; Targa A; Benítez ID; Romero-ElKhayat L; de Gonzalo-Calvo D; Torres G; Moncusí-Moix A; Huerto R; Sánchez-de-la-Torre M; Barbé F; Piñol-Ripoll G
Alzheimers Res Ther; 2020 Dec; 12(1):163. PubMed ID: 33278902
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer's Disease.
De Felice B; Montanino C; Oliva M; Bonavita S; Di Onofrio V; Coppola C
Mol Neurobiol; 2020 Nov; 57(11):4408-4416. PubMed ID: 32737762
[TBL] [Abstract][Full Text] [Related]
5. A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.
Guo R; Fan G; Zhang J; Wu C; Du Y; Ye H; Li Z; Wang L; Zhang Z; Zhang L; Zhao Y; Lu Z
J Alzheimers Dis; 2017; 60(4):1365-1377. PubMed ID: 29036818
[TBL] [Abstract][Full Text] [Related]
6. The characterization of extracellular vesicles-derived microRNAs in Thai malaria patients.
Ketprasit N; Cheng IS; Deutsch F; Tran N; Imwong M; Combes V; Palasuwan D
Malar J; 2020 Aug; 19(1):285. PubMed ID: 32778117
[TBL] [Abstract][Full Text] [Related]
7. Differential expression and significance of miRNAs in plasma extracellular vesicles of patients with Parkinson's disease.
Xie S; Niu W; Xu F; Wang Y; Hu S; Niu C
Int J Neurosci; 2022 Jul; 132(7):673-688. PubMed ID: 33045885
[TBL] [Abstract][Full Text] [Related]
8. Can Peripheral MicroRNA Expression Data Serve as Epigenomic (Upstream) Biomarkers of Alzheimer's Disease?
Yılmaz ŞG; Erdal ME; Özge AA; Sungur MA
OMICS; 2016 Aug; 20(8):456-61. PubMed ID: 27501295
[TBL] [Abstract][Full Text] [Related]
9. MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles from Patients with Alzheimer's Disease.
Serpente M; Fenoglio C; D'Anca M; Arcaro M; Sorrentino F; Visconte C; Arighi A; Fumagalli GG; Porretti L; Cattaneo A; Ciani M; Zanardini R; Benussi L; Ghidoni R; Scarpini E; Galimberti D
Cells; 2020 Jun; 9(6):. PubMed ID: 32531989
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Vesicles of Alzheimer's Disease Patients as a Biomarker for Disease Progression.
Aharon A; Spector P; Ahmad RS; Horrany N; Sabbach A; Brenner B; Aharon-Peretz J
Mol Neurobiol; 2020 Oct; 57(10):4156-4169. PubMed ID: 32676990
[TBL] [Abstract][Full Text] [Related]
11. Altered Extracellular Vesicle miRNA Profile in Prodromal Alzheimer's Disease.
Visconte C; Fenoglio C; Serpente M; Muti P; Sacconi A; Rigoni M; Arighi A; Borracci V; Arcaro M; Arosio B; Ferri E; Golia MT; Scarpini E; Galimberti D
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834197
[TBL] [Abstract][Full Text] [Related]
12. Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology.
Sierksma A; Lu A; Salta E; Vanden Eynden E; Callaerts-Vegh Z; D'Hooge R; Blum D; Buée L; Fiers M; De Strooper B
Mol Neurodegener; 2018 Oct; 13(1):54. PubMed ID: 30314521
[TBL] [Abstract][Full Text] [Related]
13. Several miRNAs derived from serum extracellular vesicles are potential biomarkers for early diagnosis and progression of Parkinson's disease.
He S; Huang L; Shao C; Nie T; Xia L; Cui B; Lu F; Zhu L; Chen B; Yang Q
Transl Neurodegener; 2021 Jul; 10(1):25. PubMed ID: 34315539
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of MicroRNAs Derived from Plasma Extracellular Vesicles in Schizoaffective Disorder.
Chen R; Shi J; Yang H; Zhang M; Chen Q; He Q
Mol Neurobiol; 2023 Nov; 60(11):6373-6382. PubMed ID: 37452221
[TBL] [Abstract][Full Text] [Related]
15. Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.
Cosín-Tomás M; Antonell A; Lladó A; Alcolea D; Fortea J; Ezquerra M; Lleó A; Martí MJ; Pallàs M; Sanchez-Valle R; Molinuevo JL; Sanfeliu C; Kaliman P
Mol Neurobiol; 2017 Sep; 54(7):5550-5562. PubMed ID: 27631879
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer's disease.
Kumar S; Vijayan M; Reddy PH
Hum Mol Genet; 2017 Oct; 26(19):3808-3822. PubMed ID: 28934394
[TBL] [Abstract][Full Text] [Related]
17. The emerging role of microRNA-4487/6845-3p in Alzheimer's disease pathologies is induced by Aβ25-35 triggered in SH-SY5Y cell.
Hu L; Zhang R; Yuan Q; Gao Y; Yang MQ; Zhang C; Huang J; Sun Y; Yang W; Yang JY; Min ZL; Cheng J; Deng Y; Hu X
BMC Syst Biol; 2018 Dec; 12(Suppl 7):119. PubMed ID: 30547775
[TBL] [Abstract][Full Text] [Related]
18. Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease.
Hara N; Kikuchi M; Miyashita A; Hatsuta H; Saito Y; Kasuga K; Murayama S; Ikeuchi T; Kuwano R
Acta Neuropathol Commun; 2017 Jan; 5(1):10. PubMed ID: 28137310
[TBL] [Abstract][Full Text] [Related]
19. Profile of pathogenic proteins in total circulating extracellular vesicles in mild cognitive impairment and during the progression of Alzheimer's disease.
Perrotte M; Haddad M; Le Page A; Frost EH; Fulöp T; Ramassamy C
Neurobiol Aging; 2020 Feb; 86():102-111. PubMed ID: 31883770
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA expression data analysis to identify key miRNAs associated with Alzheimer's disease.
Chen J; Qi Y; Liu CF; Lu JM; Shi J; Shi Y
J Gene Med; 2018 Jun; 20(6):e3014. PubMed ID: 29543360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
